CBD Life Sciences, Inc. (CBDL) Makes Progress to Triple Its Cartridge Production for Multinational Companies
CBD Life Sciences (OTC PINK:CBDL) is significantly increasing its cartridge production capacity through its subsidiary, LBC Bioscience Inc., to meet high demand from multinational pharmaceutical companies. CEO Lisa Nelson announced the addition of a new machine, aiming for a production rate of at least 1,000 cartridges daily. This expansion is anticipated to enhance revenue and growth opportunities. The global cannabidiol market is projected to grow from USD 3,675.1 million in 2021 to USD 55,791.3 million by 2028, driven by the rising adoption of CBD products for various therapeutic applications.
- Plans to triple cartridge production, potentially increasing revenue.
- Anticipation of significant growth opportunities due to high demand.
- Expansion aligns with the global CBD market projected to reach USD 55,791.3 million by 2028.
- None.
SCOTTSDALE, AZ / ACCESSWIRE / November 3, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly-owned subsidiary, LBC Bioscience Inc. announces that the company is making considerable progress to triple its cartridge production for multinational companies.
CBD Life Sciences Inc. is currently ramping up its production of cartridges due to such high demand from other companies. These multinational companies CBD Life Sciences is doing business with are in the pharmaceutical sector throughout the world. President & CEO Lisa Nelson states "With the addition of this new machine to make the cartridges, we can expect to make at least 1000 cartridges per day!" Lisa Nelson also states, "This will be a terrific way to increase revenue along with encountering huge growth opportunities as we continue to work with more and more companies who want our product on their shelves." What differentiates CBD Life Sciences Inc from the competition is all their Full Spectrum Cannabinoids contain over 7 (seven) cannabinoids offering all the benefits the industrial hemp plant has to offer. Due to using CO2 Extraction, you may find; CBD, CBDa, CBG, CBGa, CBN, CBC, & CBDV in all products as well as; Terpenoids, Aminos, Omegas, Saponins, and Flavonoids The company also decided to add six more strains to the list to provide even more of a choice for buyers.
Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the global cannabidiol market is anticipated to grow at a lucrative rate over the forecast period. Increasing awareness of cannabidiol's therapeutic benefits has influenced a buyer to buy cannabidiol products, regardless of their cost. As these have a greater profit margin, commercial retailers are now focusing on selling cannabis-based products. Numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance. In addition, CVS Health decides to offer CBD topicals all over its 800 stores and Walgreens Boots Alliance is selling CBD-containing topicals across 1500 of its stores in the U.S. Report from Fortune Business Insights said that the global cannabidiol (CBD) market size was USD 2,770.8 million in 2020. They also stated that the market is projected to grow from USD 3,675.1 million in 2021 to USD 55,791.3 million in 2028 at a CAGR of
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
LBC BIOSCIENCE INC. ONLINE STORE
LBC BIOSCIENCE'S Online Emporium
LBC Bioscience Inc. is well-stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
Become a Distributor
- Large Selection of Products (over 50 items and growing)
100% USA Made Products "organic & kosher."- All Products are THC-FREE (they contain
0.00% THC) - Weekly Deals (new deals every week)
25% off on all products using code "LBC25."
LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience
Amazon: https://www.amazon.com/shops/lbcbioscienceinc
eBay: https://www.ebay.com/usr/lbcbioscience
Alibaba: https://lbcbioscience.trustpass.alibaba.com/
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly-owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.
Ten Associates LLC
Contact: Thomas E. Nelson
Telephone: (480) 326-8577
Email: tenassociates33@gmail.com
Website: www.tenassociatesllc.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
SOURCE: CBD Life Sciences Inc.
View source version on accesswire.com:
https://www.accesswire.com/670871/CBD-Life-Sciences-Inc-CBDL-Makes-Progress-to-Triple-Its-Cartridge-Production-for-Multinational-Companies
FAQ
What is CBD Life Sciences' recent announcement regarding cartridge production?
How many cartridges does CBD Life Sciences aim to produce daily?
What is the projected growth of the global cannabidiol market?
Who is the CEO of CBD Life Sciences?
